40°01′52″N 116°18′01″E / 40.031°N 116.3003°E
 | |||||||
.jpg) | |||||||
| Company type | Public | ||||||
|---|---|---|---|---|---|---|---|
| Nasdaq: SVA | |||||||
| Founded | 1999 | ||||||
| Founder | Yin Weidong[1] | ||||||
| Headquarters | 39 Shang Di West Road, Haidian District, , China | ||||||
Number of employees | 4,281 (as of 2022)[2] | ||||||
| Chinese name | |||||||
| Simplified Chinese | 科兴控股生物技术有限公司 | ||||||
| Traditional Chinese | 科興控股生物技術有限公司 | ||||||
| Literal meaning | Kexing Holdings Biotechnology Co., Ltd. | ||||||
| |||||||
| Website | www | ||||||
Sinovac Biotech Ltd. (Chinese: 科兴控股生物技术有限公司) is a Chinese biopharmaceutical company based in Haidian District, Beijing that focuses on the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. The company was listed on the Nasdaq but the exchange halted Sinovac's trading in February 2019 due to a proxy fight.[3][4] The company has faced bribery probes in China.[3] Its COVID-19 vaccine was also the target of a covert disinformation campaign by the US government.[5]
- ^ "China's Vaccine Front-Runner Aims to Beat Covid the Old-Fashioned Way". Bloomberg. 24 August 2020. Archived from the original on 2020-09-27. Retrieved 2020-08-27.
- ^ "Submission Proof - tv479639" (PDF). file/2022/FY2021_20F_SVA_Annual.pdf Archived (PDF) from the original on 2024-01-14. Retrieved 2023-06-03.
{{cite web}}: Check|archive-url=value (help) - ^ a b Dou, Eva (December 4, 2020). "As China nears a coronavirus vaccine, bribery cloud hangs over drugmaker Sinovac". The Washington Post. ISSN 0190-8286. Archived from the original on December 4, 2020. Retrieved 2020-12-06.
- ^ Levine, Matt (May 22, 2020). "A Vaccine With a Poison Pill". Bloomberg News. Archived from the original on June 21, 2020. Retrieved December 6, 2020.
- ^ Cite error: The named reference
:6was invoked but never defined (see the help page).